Skip to main content
. 2018 Aug 7;20:88. doi: 10.1186/s13058-018-1007-x

Fig. 3.

Fig. 3

Comparison of somatic mutation frequency in inflammatory breast cancer (IBC) and non-IBC grouped by biological pathways. Data show the percentage of samples with alterations on 10 biological pathways; the gray bars indicate non-IBC, the black bars indicate IBC; *p < 0.05, **p < 0.01, ***p < 0.001